SNT
Click for more information
0.00% 3.2¢ syntara limited

time frame, page-4

  1. SNI4
    509 Posts.
    clock Created with Sketch.
    18/11/09
    18:13
    Post #: 5931464
    My mistake.
    U.S. FDA ACCEPTS ARIDOLTM NEW DRUG APPLICATION FOR REVIEW
    Pharmaxis (ASX:PXS, NASDAQ:PXSL) today announced it had received notification from the United
    States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol
    bronchial challenge test Aridol™ has been accepted for standard review. The FDA will advise the
    result of the review on 27 December 2009.

    PXS Price at posting: $2.30 Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Resource skyrockets 80% to 91Moz AgEq – exceptional grades and more drilling to come
right-arrow Created with Sketch.
NEWS First paediatric clinical site activated – major recruitment milestone and key appointment announced
right-arrow Created with Sketch.
NEWS High-grade copper & antimony results uncovered - find out who's behind it
right-arrow Created with Sketch.
NEWS A$17 Million Cash Sale of Citadel Joint Venture Interest
right-arrow Created with Sketch.
NEWS TRENDING: High grade drilling assays
right-arrow Created with Sketch.
NEWS $2.2M Placement to Expand Resources and Continue Exploration
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $41.29M
Open High Low Value Volume
3.3¢ 3.4¢ 3.2¢ $1.145K 34.80K

Buyers (Bids)

No. Vol. Price($)
3 18183 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 199241 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.